The C Allele of ATM rs11212617 Associates With Higher Pathological Complete Remission Rate in Breast Cancer Patients Treated With Neoadjuvant Metformin

The C Allele of ATM rs11212617 Associates With Higher Pathological Complete Remission Rate in Breast Cancer Patients Treated With Neoadjuvant Metformin

Background: The minor allele (C) of the single-nucleotide polymorphism (SNP) rs11212617, located near the ataxia telangiectasia mutated (ATM) gene, has been associated with an increased likelihood of treatment success with metformin in type 2 diabetes. We herein investigated whether the same SNP wou...

Volledige beschrijving

Bibliografische gegevens
Hoofdauteurs: Elisabet Cuyàs, Maria Buxó, Maria José Ferri Iglesias, Sara Verdura, Sonia Pernas, Joan Dorca, Isabel Álvarez, Susana Martínez, Jose Manuel Pérez-Garcia, Norberto Batista-López, César A. Rodríguez-Sánchez, Kepa Amillano, Severina Domínguez, Maria Luque, Idoia Morilla, Agostina Stradella, Gemma Viñas, Javier Cortés, Jorge Joven, Joan Brunet, Eugeni López-Bonet, Margarita Garcia, Samiha Saidani, Xavier Queralt Moles, Begoña Martin-Castillo, Javier A. Menendez
Formaat: Artikel
Taal:English
Gepubliceerd in: Frontiers Media S.A. 2019-03-01
Reeks:Frontiers in Oncology
Onderwerpen:
metformin
breast cancer
neoadjuvancy
HER2
ATM
rs11212617
Online toegang:https://www.frontiersin.org/article/10.3389/fonc.2019.00193/full

Internet

https://www.frontiersin.org/article/10.3389/fonc.2019.00193/full

Gelijkaardige items